HOME >> MEDICINE >> NEWS
Northwestern researchers present findings at Neuroscience Meeting

MIAMI BEACH --- Researchers from Northwestern University will present findings from their studies at the Society for Neuroscience's annual meeting to be held in Miami Beach, Fla., Oct. 23-28, 1999. The Northwestern presentations include studies of the genetic gears of the biological clock, gene therapy and its effect on Parkinson's disease and an understanding of memory and loss of memory. A summary of these three presentations follows:

Study points to genetic basis for aging of biological clock

Results from a recent study conducted at Northwestern University should help neuroscientists better understand the genes that drive human beings' biological clocks and how those genes might change as people age.

The findings, which will be presented by Northwestern graduate student Daniel Kolker, suggest that in old age the Clock gene, or one of the genes that its protein product interacts with, fails to function as well as it does in youth. This may help explain why the circadian rhythms of many species of animals, including humans, function differently or more irregularly in old age.

Kolker and colleagues studied two different groups of mice, one a normal group of animals and the other a group that had a mutation in the Clock gene, which gives those mice an abnormally functioning biological clock. The animals? circadian timing systems were monitored when they where young and later old, and all the mice exhibited a change in their daily rhythms (e.g., exercise and activity-rest cycle) when older. However, the mice with a mutated Clock gene showed a significantly greater disruption in their circadian rhythms than the normal mice. This would indicate that the Clock gene is important to the functioning of the biological clock.

Kolker, who works with circadian rhythm expert Fred Turek, Charles E. and Emma H. Morrison Professor of Biology at Northwestern, has repeated the study and is currently analyzing the data. Although no experiments have yet
'"/>

Contact: Megan Fellman
fellman@nwu.edu
847-491-3115
Northwestern University
24-Oct-1999


Page: 1 2 3 4

Related medicine news :

1. Northwestern Memorial Hospital honored with one of the nations top awards for quality
2. Northwestern Memorial physicians encourage screenings during colon cancer awareness month
3. Northwestern Memorial Hospital receives $10 million commitment to support preeminent heart program
4. Northwestern Memorial chosen to be featured in first-ever mini-med school TV airing on PBS
5. Countrys first simplified maze using new ultrasound technology is done at Northwestern Memorial
6. Northwestern Memorial Hospital testing new procedure for patients with major depression
7. Northwestern University receives $7.5 million for regenerative medicine
8. Northwestern researchers pinpoint how false memories are formed
9. Northwestern receives $2.1 million grant for Parkinsons disease research
10. Northwestern Memorial named one of nations top 12 hospital-affiliated infertility clinics
11. Blood pressure control poor in elderly, says Northwestern researcher

Post Your Comments:
(Date:4/17/2014)... One of the most popular vaccine brands for children ... may be overlooking some cost factors when choosing vaccines, ... expensive option, according to a new study by University ... administer can be driven by numerous factors," says Sheldon ... professor of computer science and of mathematics at the ...
(Date:4/17/2014)... of California, San Diego School of Medicine report that ... a recent major loss are more likely to be ... study is published in this month,s issue of the ... compassionate behaviors are associated with better health and well-being ... ways to improve the outcomes of individuals whose deficits ...
(Date:4/17/2014)... Jon McCullers, MD, was recently invited to submit ... Nature Reviews Microbiology , one of the world,s ... infectious disease specialist, and chair of the Department ... Science Center, analyzed the epidemiology and microbiology of ... as well as more recent 2009 novel H1N1 ...
(Date:4/17/2014)... MAYWOOD, Il. (April 17, 2014) Doctors who ... disease called lymphangioleiomyomatosis (LAM) can face an agonizing ... progression of the disease and help relieve shortness ... lung transplants, and sirolimus can cause potentially fatal ... said pulmonologist Dr. Daniel Dilling, medical director of ...
(Date:4/17/2014)... 17, 2014-- Colic affects about one in five infants ... pediatric visits during the first several months after birth. ... was showing promise; however, the April 1, 2014 issue ... Valerie) reported on a study, "Probiotics and Infant Colic," ... reuteri for infant colic did not reduce ...
Breaking Medicine News(10 mins):Health News:Study recalculates costs of combination vaccines 2Health News:The ilk of human kindness 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com announces ... available in its catalogue: ... Drug Delivery Systems -- Focus on End ... STUDY OBJECTIVES A drug ...
(Date:1/15/2014)... 15, 2014  Zafgen, Inc., a leading biopharmaceutical company ... obese patients, today announced initial results from its ... of methionine aminopeptidase 2 (MetAP2), in patients with ... obesity.  These results showed improvements in body weight, ...
(Date:1/14/2014)... HeartWare International, Inc . (NASDAQ: ... circulatory support technologies that are revolutionizing the treatment of ... for the fourth quarter of 2013 will be approximately ... $208 million. "Our full-year revenue growth of ...
Breaking Medicine Technology:Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4
Cached News: